What increasing confidence in Biogen's latest Alzheimer's drug means for Eli Lilly - CNBC
What increasing confidence in Biogen's latest Alzheimer's drug means for Eli Lilly - CNBC
Nov 30, 202211 secs
It's a development that may carry positive implications for Eli Lilly (LLY) because the Club holding is investigating a similar drug targeting the disease.